Eurofound's EU PolicyWatch collates information on the responses of government and social partners to the COVID-19 crisis, the war in Ukraine, rising inflation, as well as gathering examples of company practices aimed at mitigating the social and economic impacts.
Factsheet for measure FR-2020-47/1462 – measures in France
Country | France , applies nationwide |
Time period | Open ended, started on 17 November 2020 |
Context | COVID-19 |
Type | Legislations or other statutory regulations |
Category |
Protection of workers, adaptation of workplace
– Occupational health and safety |
Author | Frédéric Turlan (IRshare) and Eurofound |
Measure added | 26 November 2020 (updated 27 November 2020) |
An order of 16 November provides, by amending an order of 10 July 2020, that, exceptionally, an employer may organise collective screening operations, using rapid diagnostic nasopharyngeal antigenic orientation tests for the detection of SARS-Cov 2, within targeted populations, in the event of suspicion of a "cluster" or particularly active circulation of the virus, after declaration to the State representative in the department.
The order notes state that 'the evolution of the epidemic makes it necessary to increase the testing capacity on the national territory' and that 'it is advisable to extend the use of rapid antigenic diagnostic tests and to supervise their use'. Therefore, exceptionally, an employer may organise collective screening operations, using rapid diagnostic nasopharyngeal antigenic orientation tests for the detection of SARS-Cov 2, within targeted populations, in the event of suspicion of a "cluster" or particularly active circulation of the virus, after declaration to the State representative in the department.
The tests are carried out by a doctor, nurse or pharmacist who themselves give the results to the people tested. This possibility is provided for in the national protocol to ensure the health and safety of employees in companies in the face of the COVID-19 epidemic, since its update of 29 October 2020. In this context, the employer must finance all the screening actions and the results of the tests cannot be communicated to him.
No information available.
Workers | Businesses | Citizens |
---|---|---|
Applies to all workers | Applies to all businesses | Does not apply to citizens |
Actors | Funding |
---|---|
National government
Company / Companies |
Companies
Employer |
Social partners' role in designing the measure and form of involvement:
Trade unions | Employers' organisations | |
---|---|---|
Role | No involvement | No involvement |
Form | Not applicable | Not applicable |
Social partners' role in the implementation, monitoring and assessment phase:
No involvement, this in a governmental decision.
No information available.
Citation
Eurofound (2020), Authorisation for employers to organise collective screening of employees, measure FR-2020-47/1462 (measures in France), EU PolicyWatch, Dublin, https://static.eurofound.europa.eu/covid19db/cases/FR-2020-47_1462.html
Share
30 January 2023
Governments across the EU continue to implement policies to support citizens and businesses in the face of rising food and energy prices caused by the COVID-19 crisis and intensified by the war in Ukraine. This article summarises the policy responses as reported in Eurofound's EU PolicyWatch database from January to September 2022.
Article12 September 2022
Although the worldwide pandemic situation had already disrupted supply chains and triggered increases in energy and food prices in 2021, the situation deteriorated in 2022 with the Russian invasion of Ukraine.
Article12 September 2022
This article summarises the first policy responses that governments across the EU have started to implement to support companies affected by the rising prices, and those with commercial ties to Ukraine, Russia or Belarus.
Article5 July 2022
This article summarises the first policy responses of EU Member States, including those of the social partners and other civil society actors, enabling refugees to exercise their rights under the Temporary Protection Directive.
ArticleDisclaimer: This information has not been subject to the full Eurofound evaluation, editorial and publication process.